Načítá se...

Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones

Two recent papers identify KRAS activation as a mechanism of acquired resistance to EGFR blockade in colorectal cancer. In doing so, they suggest that resistance to single-agent EGFR blockade will be unavoidable because these alterations exist as latent subclones within the tumor even prior to the i...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Konieczkowski, David J, Garraway, Levi A
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3541651/
https://ncbi.nlm.nih.gov/pubmed/22847744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2012.115
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!